Astrazeneca shares fall after FTSE giant’s forecast lift fails to inspire
In the first half of 2024, Astrazeneca reported an 18 per cent year-on-year increase in total revenue, reaching $2.6bn (£2bn).
Talktalk: The telecoms titan on the brink
In a defining few months, Talktalk needs to refinance nearly a billion pounds of debt, with bidders circling. Will it survive?
Revolut’s long wait for a banking licence finally comes to an end
After more than three years, Revolut’s wait for a banking licence is finally over after it received authorisation from the banking watchdog. Revolut said it would now enter the ‘mobilisation‘ st
Veterinary group CVS gears up for Australia expansion
Veterinary group CVS announced 10 per cent revenue growth but weaker sales amid soft demand and the effect of a cyber security attack, while it separately announced a shift in strategy to focus on gro